Cabaletta Bio, Inc. Common Stock
Symbol: CABA (NASDAQ)
Company Description:
Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.
- Today's Open: $2.32
- Today's High: $2.394
- Today's Low: $2.285
- Today's Volume: 1.22M
- Yesterday Close: $2.34
- Yesterday High: $2.39
- Yesterday Low: $2.235
- Yesterday Volume: 1.83M
- Last Min Volume: 0
- Last Min High: $2.304
- Last Min Low: $2.295
- Last Min VWAP: $0
- Name: Cabaletta Bio, Inc. Common Stock
- Website: https://www.cabalettabio.com
- Listed Date: 2019-10-25
- Location: PHILADELPHIA, PA
- Market Status: Active
- CIK Number: 0001759138
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $214.03M
- Round Lot: 100
- Outstanding Shares: 91.47M
- Asset Type: CS
Filing Date | Filing Type | Format |
---|---|---|
2025-09-03 | 8-K | View |
2025-08-15 | EFFECT | View |
2025-08-14 | SCHEDULE 13G | View |
2025-08-14 | SCHEDULE 13G/A | View |
2025-08-14 | SCHEDULE 13G | View |
2025-08-13 | CORRESP | View |
2025-08-13 | UPLOAD | View |
2025-08-12 | SCHEDULE 13G/A | View |
2025-08-11 | SCHEDULE 13G/A | View |
2025-08-07 | S-3 | View |
2025-08-07 | 10-Q | View |
2025-08-07 | 8-K | View |
2025-08-06 | SCHEDULE 13G/A | View |
2025-08-06 | SCHEDULE 13G/A | View |
2025-07-29 | SCHEDULE 13G/A | View |
2025-07-16 | SCHEDULE 13G/A | View |
2025-06-20 | SCHEDULE 13G | View |
2025-06-12 | 8-K | View |
2025-06-12 | 424B5 | View |
2025-06-11 | 424B5 | View |